http://orcid.org/0000-0002-3547-3671
Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Xiao Yu, H Karl Greenblatt & David J Greenblatt. (2023) Designer benzodiazepines: an update. Expert Review of Clinical Pharmacology 16:2, pages 109-117.
Read now
Read now
James J. Reeves, Andrew D. Brown & Brent S. Collier. (2022) Designer benzodiazepine dependence and the difficulties of outpatient management; a case report. Journal of Addictive Diseases 0:0, pages 1-5.
Read now
Read now
Mark Haden, Josephine Cashman, Andrew Ketchin, Rebecca Macfarlane, Shabana Issa, Michael Eddleston, Selina Hines, Simon Hudson, Simon L. Hill & Simon H. L. Thomas. (2022) Detection of flubromazolam in patients with suspected non-medical drug use attending emergency departments in the United Kingdom. Clinical Toxicology 60:1, pages 33-37.
Read now
Read now
Michael E. Mullins. (2020) Fentanyl, Inc.. Clinical Toxicology 58:12, pages 1350-1350.
Read now
Read now
Xander M. R. Van Wijk, Robert Goodnough & Jennifer M. Colby. (2019) Mass spectrometry in emergency toxicology: Current state and future applications. Critical Reviews in Clinical Laboratory Sciences 56:4, pages 225-238.
Read now
Read now
Lauren Murphy, Jonathan Melamed, Roy Gerona & Robert G. Hendrickson. (2019) Clonazolam: a novel liquid benzodiazepine. Toxicology Communications 3:1, pages 75-78.
Read now
Read now
Articles from other publishers (34)
Rebekka Syrjanen, Shaun L. Greene, Courtney Weber, Jennifer L. Smith, Sarah E. Hodgson, Rachelle Abouchedid, Dimitri Gerostamoulos, Jacqueline Maplesden, Jonathan Knott, Hans Hollerer, Joe-Anthony Rotella, Andis Graudins & Jennifer L. Schumann. (2023) Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia: results from the Emerging Drugs Network of Australia - Victoria project 2020-2022. International Journal of Drug Policy 122, pages 104245.
Crossref
Crossref
Donna M Papsun, Ayako Chan-Hosokawa, Michael E Lamb & Barry Logan. (2023) Increasing prevalence of designer benzodiazepines in impaired driving: A 5-year analysis from 2017 to 2021. Journal of Analytical Toxicology 47:8, pages 668-679.
Crossref
Crossref
Souleiman El Balkhi & Chadi Abbara. (2023) Designer Benzodiazepines: Effects, Toxicity, and Interactions. Therapeutic Drug Monitoring 45:4, pages 494-507.
Crossref
Crossref
A. Yu. Simonova, K. K. Ilyashenko, M. V. Belova & M. M. Potshveria. (2023) Features of Benzodiazepine Poisoning in the Elderly and Senile Patients. Russian Sklifosovsky Journal "Emergency Medical Care" 12:1, pages 37-44.
Crossref
Crossref
Mireia Pérez Orts, Arian van Asten & Isabelle Kohler. (2023) The Evolution Toward Designer Benzodiazepines in Drug-Facilitated Sexual Assault Cases. Journal of Analytical Toxicology 47:1, pages 1-25.
Crossref
Crossref
Ran Kong, Junbo Zhao, Wenya Zhai, Zhuonan Chen, Shuo Yang, Mobing Chen, Jiaman Lin, Lina Wu, Wanhui Liu & Ping Xiang. (2023) Metabolic profiling of clonazolam in human liver microsomes and zebrafish models using liquid chromatography quadrupole Orbitrap mass spectrometry. Journal of Chromatography B 1216, pages 123583.
Crossref
Crossref
Sarah M R Wille, Malika Bouazzati, Jari Rubbens, Vincent Di Fazio & Nele Samyn. (2022) Combined Use of Flubromazepam and Stimulants: Blood and Oral Fluid Concentrations and Impact on Driving Ability. Journal of Analytical Toxicology 46:9, pages e280-e284.
Crossref
Crossref
Islam Amine Larabi & Jean-Claude Alvarez. 2023. Methods for Novel Psychoactive Substance Analysis. Methods for Novel Psychoactive Substance Analysis
93
123
.
Brian Rossi, Francesca Freni, Claudia Carelli, Matteo Moretti, Dario Galatone, Claudia Vignali & Luca Morini. (2022) Determination of Traditional and Designer Benzodiazepines in Urine through
LC-MS/MS. Current Pharmaceutical Design 28:32, pages 2622-2638.
Crossref
Crossref
Eunchong Hong, Sun Mi Gu, Jin Mook Kim, Kyung Sik Yoon, Jin-Moo Lee, Young-Hoon Kim, Soo Kyung Suh, Dohyun Lee, Heejong Eom, Jaesuk Yun & Hye Jin Cha. (2022) The designer benzodiazepine, flubromazepam, induces reward-enhancing and cardiotoxic effects in rodents. Toxicology Research 11:4, pages 644-653.
Crossref
Crossref
Jiang Ling, Wenqi Zhang, Xiaojun Yan, Wenlong Liu, Yanyan Wang & Yanjun Ding. (2022) Sensitive detection and primary metabolism analysis of flualprazolam in blood. Journal of Forensic and Legal Medicine 90, pages 102388.
Crossref
Crossref
A.W. Jones, F. Musshoff, T. Krämer, A. E. Steuer, D. Gerostamoulos, O.H. Drummer, G. Drasch, M. Balikova, J. Beyer, H. Teixeira, M. Thevis, W. Schänzer, H. Druid & G. Skopp. 2022. Handbook of Forensic Medicine. Handbook of Forensic Medicine
1167
1312
.
Meiru Pan, Brian Schou Rasmussen, Petur Weihe Dalsgaard, Christian Brinch Mollerup, Marie Katrine Klose Nielsen, Michael Nedahl, Kristian Linnet & Marie Mardal. (2022) A New Strategy for Efficient Retrospective Data Analyses for Designer Benzodiazepines in Large LC-HRMS Datasets. Frontiers in Chemistry 10.
Crossref
Crossref
Shane Darke, Amy Peacock, Johan Duflou, Michael Farrell & Julia Lappin. (2022) Characteristics of fatal ‘novel’ benzodiazepine toxicity in Australia. Forensic Science International 331, pages 111140.
Crossref
Crossref
Sharon Essink, Johanna J. Nugteren-van Lonkhuyzen, Antoinette J.H.P. van Riel, Douwe Dekker & Laura Hondebrink. (2022) Significant toxicity following an increase in poisonings with designer benzodiazepines in the Netherlands between 2010 and 2020. Drug and Alcohol Dependence 231, pages 109244.
Crossref
Crossref
John R.H. Archer. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
131
156
.
Christopher Yates & Piotr M. Kabata. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
181
202
.
Caitlin Wolfe. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
475
494
.
Matthias E. Liechti, Linda D. Simmler, Harald H. Sitte & Dino Luethi. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
109
130
.
Arianna Giorgetti, Michaela J. Sommer, Maurice Wilde, Markus Große Perdekamp & Volker Auwärter. (2021) A case of fatal multidrug intoxication involving flualprazolam: distribution in body fluids and solid tissues. Forensic Toxicology 40:1, pages 180-188.
Crossref
Crossref
Andreas BüttnerAndreas Büttner. 2022. Neuropathologie des Drogenmissbrauchs. Neuropathologie des Drogenmissbrauchs
23
90
.
Matthew K. Laing, Lianping Ti, Allison Marmel, Samuel Tobias, Aaron M. Shapiro, Richard Laing, Mark Lysyshyn & M. Eugenia Socías. (2021) An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods. International Journal of Drug Policy 93, pages 103169.
Crossref
Crossref
Pietro Brunetti, Raffaele Giorgetti, Adriano Tagliabracci, Marilyn Huestis & Francesco Busardò. (2021) Designer Benzodiazepines: A Review of Toxicology and Public Health Risks. Pharmaceuticals 14:6, pages 560.
Crossref
Crossref
Peter D Maskell, Claire Parks, Jenny Button, Huiling Liu & Denise A McKeown. (2021) Clarification of the Correct Nomenclature of the Amino Metabolite of Clonazolam: 8-Aminoclonazolam. Journal of Analytical Toxicology 45:2, pages e1-e2.
Crossref
Crossref
Maarten Degreef, Lore Vits, Eleanor M Berry, Kristof E K Maudens & Alexander L N van Nuijs. (2021) Quantification of 54 Benzodiazepines and Z-Drugs, Including 20 Designer Ones, in Plasma. Journal of Analytical Toxicology 45:2, pages 141-153.
Crossref
Crossref
Andreas BüttnerAndreas Büttner. 2021. Neuropathology of Drug Abuse. Neuropathology of Drug Abuse
23
87
.
Gunhild Heide, Gudrun Høiseth, Gerrit Middelkoop & Åse Marit Leere Øiestad. (2020) Blood Concentrations of Designer Benzodiazepines: Relation to Impairment and Findings in Forensic Cases. Journal of Analytical Toxicology 44:8, pages 905-914.
Crossref
Crossref
Laura Orsolini, John M. Corkery, Stefania Chiappini, Amira Guirguis, Alessandro Vento, Domenico De Berardis, Duccio Papanti & Fabrizio Schifano. (2020) ‘New/Designer Benzodiazepines’: An Analysis of the Literature and Psychonauts’ Trip Reports. Current Neuropharmacology 18:9, pages 809-837.
Crossref
Crossref
Meng Xia, Delun Huang, Yuangming Tong & Jiang Lin. (2020) Pearl powder reduces sleep disturbance stress response through regulating proteomics in a rat model of sleep deprivation. Journal of Cellular and Molecular Medicine 24:9, pages 4956-4966.
Crossref
Crossref
Suzanne Nielsen & Andrew McAuley. (2020) Etizolam: A rapid review on pharmacology, non‐medical use and harms. Drug and Alcohol Review 39:4, pages 330-336.
Crossref
Crossref
Anders Helander, Matilda Bäckberg & Olof Beck. (2020) Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project. PLOS ONE 15:4, pages e0232038.
Crossref
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Crossref
Tim Bühler, Yasmin Schmid & Matthias E. Liechti. (2019) Verdacht auf K.o.-Mittel: Diagnostik in der Notfallstation und Praxis. Praxis 108:13, pages 869-876.
Crossref
Crossref
Evelyn S. Ligon, Jason Nawyn, Lonnie V. Jones, B. McKay Allred, Daniel V. ReinhardtJr.Jr. & Stefan France. (2019) Synthesis of Flubromazepam Positional Isomers for Forensic Analysis. The Journal of Organic Chemistry 84:16, pages 10280-10291.
Crossref
Crossref